Nonetheless, this study underscores the critical need for sex- and (APOE) genotype-specific approaches in AD therapy and is a step towards tailored personalized therapeutic approaches in AD/neurodegeneration, and the identified neutrophil subset and associated molecular signatures could serve as biomarkers for early detection or monitoring of AD progression in at-risk populations. Here, APOE is linked to Alzheimer disease.